Big Move For Sonoma Pharmaceuticals, Inc.
Thu, Jul 11, 2024 at 07:22 PM
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ) soared at $0.35, a gain of 38%. On Thu, Jul 11, 2024, SNOA:NASDAQ hit a New 2-Week Intraday High of $0.47. The stock got featured on our News Catalysts scanner on Mon, Jun 17, 2024 at 06:46 PM in the 'EARNINGS' category. From Thu, Jun 27, 2024, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Thu, Jul 11, 2024 at $0.47 with a volume of 28M+.
About Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ)
Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.
Top 10 Gainers:
- Locafy Limited (LCFY:NASDAQ), 158.47%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 85.57%
- Cyngn Inc. (CYN:NASDAQ), 85.1%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75%
- NexImmune Inc. (NEXI:NASDAQ), 68.67%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 51.88%
- Methode Electronics, Inc. (MEI:NYSE), 45.76%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 38.04%